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of Escherichia coli isolated from the gastrointestinal tracts of european starlings (Sturnus vulgaris) 
found on concentrated animal feeding operations (CAFOs). European starlings may be present in high 




respectively. Multidrug resistance in the E. coli isolates collected (n = 236) was common, with the 
majority of isolates displaying resistance to six or more classes of antibiotics. Genetic analyses of a 
subset of these isolates identified 94 genes putatively contributing to AMR, including seven class A and 





Antibiotic use in animal agriculture for prophylaxis, therapy, and growth promotion is generally recognized to 
coincide with the proliferation of antimicrobial resistance (AMR) in associated bacterial communities1–3. This is 
problematic not only for animal agriculture, but also because many antibiotics used in livestock are identical in 
structure or function to those used in human medicine4,5. Furthermore, the use of antibiotics in food animals is 
predicted to increase globally for the foreseeable future and is expected to exacerbate the AMR problem6.
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AMR development and circulation in livestock systems and the subsequent transmission of AMR bacteria 
and genes to humans is a complex dynamic with numerous inputs and outflows, often framed as part of the 
OneHealth continuum with direct and indirect costs to health, the environment, and the economy7,8. While cer-
tain environmental inputs, including human, animal, and manufacturing waste, have received significant atten-
tion in promoting AMR, less is known about the contributions of other ecological pathways, including wildlife 
incursions and dispersal9. Nonetheless, it is recognized that wildlife, such as rodents, birds, and mesocarnivores 
that frequent animal production facilities, harbor AMR bacteria with similar AMR phenotypes and genotypes to 
those found in bacteria from associated livestock10–14.
The involvement of wild birds in the maintenance and dissemination of AMR across agricultural landscapes 
is particularly intriguing due to the ability of birds, especially migratory birds, to transport and shed bacteria 
in their feces over large distances15. Frequent carriage of AMR bacteria and AMR genes has been reported for 
multiple species of wild birds12,14,16–20. Thus, bird species that are in frequent contact with anthropogenic foci of 
AMR, such as livestock production, may play an important role in the dissemination and propagation of AMR 
across the landscape.
European starlings (Sturnus vulgaris) are peridomestic birds that are invasive agricultural pests in the United 
States. They are one of North America’s most numerous songbirds with a population estimated at greater than 
200 million birds21. These birds can congregate in large flocks on concentrated animal feeding operations 
(CAFOs), with roosts often reaching over 100,000 individuals, especially in the absence of a naturally occur-
ring food source22. We have observed European starling movement between livestock production facilities, with 
reported banding and recovery data indicating that these birds may migrate distances exceeding 1,500 km in 
North America23. European starlings also thrive in urban landscapes, where food, water, and nesting resources 
are met21. Given these behavioral and ecological propensities, European starlings were hypothesized to play an 
important role in the dissemination of pathogenic bacteria, including AMR bacteria, to livestock and subse-
quently humans24–27. In our companion work, we identified that the total population of European starlings found 
on CAFOs was positively correlated with cattle fecal shedding of ciprofloxacin (CIP)-resistant Escherichia coli 
(E. coli), further highlighting an important role of these birds in the maintenance and dissemination of AMR28.
The prevalence and diversity of AMR in European starlings associated with livestock operations remain 
largely uncharacterized, and have not been studied using high resolution genomic analyses. Based on our current 
knowledge of the ecology of European starlings and AMR, we hypothesized that these birds play an important 
role in the mechanical transmission of AMR among CAFO’s across large geographical distances, with trans-
mission patterns displaying elements of clonality. Thus, the objective of the present study was to subject specific 
AMR indicator E. coli present within CAFO-associated European starlings to sequential analyses to characterize 
potential transmission dynamics. Specifically, indicator E. coli with phenotypic resistance to fluoroquinolones 
and third-generation cephalosporins (3G-C) were targeted due to the classification of these antibiotics as critical 
AMR priorities4,29. Indicators were collected from European starlings within an extensive network of 31 feedlots 
in five U.S. states. A suite of phenotypic and molecular analyses were performed to assess AMR and phylogenetic 
relationships of these isolates.
Results
occurrence of AMR E. coli in European starling gastrointestinal tracts.  A total of 339 presumptive 
E. coli isolates displaying resistance to subinhibitory concentrations of cefotaxime (CTX) or CIP were collected 
using culture-based methods from 1,477 European starling gastrointestinal tracts. These birds were obtained 
from feedlots located in major beef cattle production areas in the United States. From the collected isolates, 236 
were confirmed as E. coli via matrix assisted laser desorption/ionization (MALDI) biotyping, with 60 isolates 
(from 59 birds) obtained from CTX-selection (prevalence of 4%) and 176 isolates (from 150 birds) obtained 
using CIP-selection (prevalence of 10%) (Supplementary Table 1). There were 42 birds with confirmed E. coli 
isolates obtained from both CTX- and CIP-selection. The majority of the confirmed E. coli isolates (n = 206) were 
collected in Kansas and Texas.
Extensive drug resistance in E. coli isolates from European starlings.  The 236 isolates confirmed as 
E. coli were subject to phenotypic assessments of antimicrobial susceptibility to 18 different antibiotics in order to 
1) establish whether clinically significant resistance was present to priority antibiotics, 2) determine the diversity 
and extent of multidrug resistance in these isolates, and 3) compare antibiograms for subtyping (Fig. 1).
Among CTX- and CIP-selected isolates, 95% and 94% of these isolates, respectively, displayed clinically sig-
nificant levels of resistance to the antibiotics used for selection. As expected, culture-based selection influenced 
the antimicrobial susceptibility patterns observed. CTX-selected isolates and CIP-selected isolates were gener-
ally resistant to β-lactam antibiotics and to quinolones, respectively (Figs. 1a and 1b). More than 88% of the 
isolates were resistant to tetracycline (TET). A greater proportion of CIP-selected isolates (57% of isolates) were 
resistant to sulfamethoxazole/trimethoprim (SXT) compared to isolates selected with CTX (10% of isolates). 
None of the isolates tested here were found to have resistance to carbapenems (i.e. imipenem; IMP). On aver-
age, CTX-selected E. coli isolates were resistant to 9 of the antibiotics tested, whereas the CIP-selected E. coli 
were resistant to 7.3 antibiotics (Figs. 1c and 1d). Additionally, these isolates were resistant to an average of 6 
different classes of antibiotics (see Supplementary Table 1 for the antibiotic classes tested). Phenotypic testing 
allowed for grouping of these isolates into 42 different antibiograms with unique AMR phenotypes to β-lactams 
(Supplementary Table 2). The antibiograms comprised between 1 and 29 isolates, which displayed resistances to 
as few as one β-lactam (ampicillin; AMP) to as many as 8 β-lactams (all β-lactams tested excluding IPM).
PCR-based characterizations of β-lactamase genes and determinations of E. coli phylo-
types.  Confirmed E. coli isolates (n = 187) which demonstrated resistance to any of the nine β-lactam 
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antimicrobials included in the testing panel were further typed by conventional PCR to screen for several major 
class A β-lactamase genes. β-lactamase genes identified included blaAmpC-CIT (n = 56 isolates), blaCTX-M (n = 35 
isolates), and blaTEM (n = 90 isolates) (Supplementary Table 2).
The presence of blaAmpC-CIT was identified in isolates exhibiting a broad spectrum of resistance, often confer-
ring resistance to all β-lactam antimicrobials tested (except IPM). Such relationships between the presence of 
blaAmpC-CIT and the β-lactam resistance phenotypes observed is highlighted in isolates belonging to antibiograms 
# 8, 20, and 22. The presence of blaTEM was determined in the isolates which were more frequently comprised in 
antibiograms # 3, 4, 5, 6, 34, 35, 40, and 41, and primarily conferred resistance to penicillins (AMP, piperacillin; 
PIP) or intermediate resistance to cefazolin (CFZ) and amoxicillin-clavulanate (AMC). blaCTX-M was detected pri-
marily in isolates grouped within antibiograms # 11, 16, 17, 25, and 27, and was mostly linked to AMR involving 
increased resistance to first-generation (1G-C) and second-generation (2G-C) cephalosporins. The association 
of TEM-1 and TEM-2 with increased hydrolysis of penicillins and 1G-C, and that of blaCTX-M (blaCTX-M-15) with 
increased hydrolysis of other β-lactams and monobactams is well established30.
PCR-based phylotyping classified 29, 120, 36, 1, and 1 isolates as E. coli phylotypes A, B1, D, B2, and C, 
respectively. Often, the presence of blaAmpC-CIT (CIT-type AmpC β-lactamases, including blaCMY-2,-3,-4, blaLAT-1, 
blaLAT-2, blaBIL-1) was found in isolates from phylogroups B1 and D, and the presence of blaTEM in isolates from 
phylogroups A and B1, and blaCTX-M was associated with phylogroups B1 and D (Supplementary Table 2).
Genetic context of AMR in E. coli collected from European starlings.   A prioritized subset of 66 
isolates was selected for whole genome sequencing (WGS). In silico analyses of the partial genomes identified a 
total of 3,435 AMR genetic determinants (94 unique putative AMR genes), with between 35 and 61 unique genes 
identified per isolate. The majority of the putative AMR genes were associated with drug efflux, and numerous 
genes involved in antibiotic inactivation and target alteration were identified (Table 1).
Bioinformatic analyses of isolate genomes identified a total of 81 unique genetic resistance determinants that 
were differentially present or absent among the E. coli strains tested (Supplementary Table 3). Focusing these 
analyses on priority AMR phenotypes, seven genes putatively involved in β-lactam resistance, including blaampC 
(n = 64 isolates), blaCMY-2 (n = 38 isolates), blaCTX-M-1 (n = 9 isolates), blaCTX-M-27 (n = 1 isolate), blaCTX-M-32 (n = 2 
isolates), blaTEM-1 (n = 21 isolates), and blaTEM-141 (n = 1 isolate) were identified (Fig. 2). Further, seven genes 
specifically associated to quinolone resistance were detected, including emrA (n = 65 isolates), emrB (n = 63 
isolates), mutations of gyrA (n = 22 isolates), mdtM (n = 62 isolates), mutations of parC (n = 19 isolates), qacH 
(n = 1 isolate), and qnrB10 (n = 5 isolates) (Fig. 3). Resistance to quinolones and fluoroquinolones was gener-
ally observed in isolates with mutations in gyrA and parC which are widely recognized for their ability to con-
fer increased resistance to these antibiotics. It is important to note that the associations of several of the AMR 
genes identified in these homology-based searches are only weakly linked to phenotypic resistance, including the 
observed mutations and variants of PBP3, emrA, emrB, mdtM, qacH, and qnrB10. In addition, 12 determinants 
Figure 1. Extent and diversity of clinically significant AMR phenotypes in CTX- and CIP-selected E. coli 
isolates collected from European starlings on CAFOs. Percent of (a) CTX-selected and (b) CIP-selected E. coli 
isolates for resistance to 18 antibiotics. The number of antibiotics resisted by (c) CTX-selected and (d) CIP-
selected E. coli isolates.
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potentially associated with antibiotic efflux, and subsequent AMR to β-lactams and quinolones, were detected 
(Supplementary Table 3).
Analyses of the predicted protein structures indicated that blaCMY-2, blaCTX-M-1, and blaCTX-M-32 were conserved 
among the isolates tested here. Two distinct sequence variants of blaTEM-1 were present, with three isolates having 
an N-terminal truncation, which removed the first 28 amino acids compared to the other isolates (sequences 
otherwise identical except for V29 to M29 in isolates with the truncated determinant). Structural variability 
in blaamp genes was linked to both a conserved N-terminal truncation as well as amino acid substitutions at 35 
different sites.
Phylogenetic relationships and molecular epidemiology of AMR E. coli collected from european 
starlings.  Phylogenetic analysis of the 66 sequenced E. coli genomes showed that the core genomes of the 
isolates did not always align with isolates within respective collection sites, rather several isolates showed higher 
similarity with disparate sites across the four states represented in sequenced samples (Fig. 4). Geographically 
separate isolate groups displayed up to 99.9% similarity at the nucleotide level and up to 100% in shared cod-
ing sequences (CDS; Supplementary Table 4) across their assembled genomes and exhibited identical or nearly 
identical AMR phenotypes and molecular features predicted in silico (Supplementary Tables 2 and 3). Four of the 
isolate groups were collected on farms separated by 21–183 km (Supplementary Table 4).
Predictions of serotypes in silico were unambiguous for 40 of the E. coli isolates, with 28 unique serotypes 
detected (Supplementary Table 5). According to the Enterobase database (https://enterobase.warwick.ac.uk/
species/index/ecoli, accessed 10/2/19), serotypes identified here, including O109:H21, O11:H15, O159:H28, 
O29:H21, O8:H21, and O9:H7, were previously associated with disease in humans, and a number of these E. coli 
serotypes were previously found in cattle (including O10:H42, O136:H16, and O9:H9), food products includ-
ing poultry and leafy greens (including O11:H15, O136:H16, O18ac:H49, O8:H16, and O8:H20), and wildlife 
(including O10:H42, O109:H21, O11:H15, O172:H23, and O8:H21).
Two multilocus sequence typing schemes were used for further subtyping assessment of the E. coli isolates 
(Supplementary Table 5), with 23 and 18 clonal groups detected with high confidence, respectively. According to 
the Enterobase database, the majority of the E. coli sequence types (ST) identified here are recognized to occur in 
livestock, food, wildlife, as well as the environment and were previously shown to have priority AMR phenotypes/
genotypes. E. coli isolates 1567 (ST4542) and 2966 (ST4380) had exceedingly rare STs, with less than 10 entries for 
these STs described in the Enterobase database. These STs were previously observed in poultry-associated isolates 
from China, and are primarily recognized in Asia and the Philippines, although ST4380 was also detected in a 
blaCTX-M-55-carrying E. coli isolate collected from a monkey in France in 201131.
Discussion
In this study, we examined the AMR phenotypes and molecular epidemiology of CTX and CIP-resistant E. coli 
at the interface of livestock and European starlings. Importantly, we provide evidence for genetically conserved 
AMR isolates in European starlings separated by distances exceeding 150 km on cattle production facilities in the 
Central United States. While directionality of the exchange of these bacteria could not be specifically inferred, 
our data strongly suggest that European starlings are involved in interstate dissemination of specific lineages of 
bacteria with priority AMR phenotypes. Our future research efforts will determine if AMR strains harbored by 
these birds can become established in cattle and CAFO environments.
The identification of CIP- and CTX-resistant E. coli in European starlings from CAFOs was not altogether 
unexpected, as AMR in the microbial communities associated with livestock production is widespread and is 
linked to a diverse array of phenotypic and genetic determinants32. The observation that CTX-selected isolates 
were resistant to a greater number of antibiotics was also not surprising  considering the types of antibiotics 
included in the testing panel. Specifically, nine different β-lactams were employed in susceptibility testing, more 
than any other type of antimicrobial. Further, AMR in CTX-selected isolates was mediated by genetic determi-
nants which typically conferred resistance to a broad range of antimicrobials.
The dynamics of AMR dissemination and introduction into agricultural systems are difficult to interpret 
considering the number of events and sources in which AMR bacteria could be introduced and disseminated. 
Mechanism of action # determinants
antibiotic efflux 2256
antibiotic efflux; antibiotic target alteration 198
antibiotic inactivation 276
antibiotic target alteration 461
antibiotic target alteration; antibiotic efflux 5
antibiotic target protection 39
antibiotic target replacement 69
reduced permeability to antibiotic; antibiotic 
efflux 66
reduced permeability to antibiotic; antibiotic 
efflux; antibiotic target alteration 65
Table 1. Number and type of AMR determinants predicted in 66 priority E. coli isolates collected from 
European starlings.
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Nonetheless, based on current research, a logical assumption is that competent wildlife hosts that are found in 
high numbers on livestock facilities and can travel over large distances would be particularly important contrib-
utors to AMR in these settings. High resolution analyses of the genetic backgrounds of such a diversity of E. coli 
isolates obtained from European starlings had not been investigated previously. This information is critical for 
assessing the potential role of European starlings as contributors to AMR in livestock production. Molecular 
typing revealed striking similarities between serotypes and STs from European starlings and isolates from food 
animals, food, humans, and the environment. This information, in conjunction with the high degree of genomic 
conservation between certain isolates found in European starlings, provides evidence that clonal spread of AMR 
E. coli may be mediated by these birds. Similarly, a role of European starlings in the clonal dissemination of the 
foodborne bacterium Campylobacter jejuni in cattle operations has been previously suggested33, even though 
the analysis of evolutionary relationships of E. coli using molecular typing more closely aligns with reticulate 
evolution as opposed to clonality34. Further, evidence points to presence of multi-resistant E. coli clones (i.e. 
Figure 2. In silico assessments of AMR genes found within 66 E. coli isolates collected from European starlings 
that were predicted to confer resistance to β-lactams. CARD-RGI analyses of isolates identified a total of 8 genes 
which putatively confer resistance to β-lactams. An additional 12 genes putatively involved in efflux of both 
β-lactams and quinolones were identified (see Supplementary Table 3). The column labeled ‘AMR’ represents 
phenotypic resistance characterization, and it is matched by row to the genotypic data presented in the left 
side columns. Cells shaded in white indicate that the gene was not present or the isolate was susceptible to the 
particular drug.
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ST131, ST69, ST23) in animals (companion and food animals), foods, and the environment, indicating com-
plex transmission patterns and wide distribution35. In our work, we observed no preponderance of specific STs, 
although certain patterns have emerged, as for example the identification of ST10 in several isolates associated 
with Inc-type plasmids, with this ST linked by others to both production of ESBL enzymes36 and hyperexpression 
of AmpCs37.
Multiple studies have suggested that interactions between CAFO cattle and wildlife, including European star-
lings, contribute to increased cattle infection/fecal shedding of AMR bacteria, and environmental dissemination 
of AMR bacteria22,24,38–40. This risk is further highlighted in a study by Medhanie et al. which suggested that 
increased prevalence of CTX and CIP-resistant E. coli in bovine feces correlated with increased populations of 
European starlings, and that the distance between livestock facilities and European starling roosts was signifi-
cantly associated with the presence of these AMR indicators41. A similar result was achieved in the companion 
study to this work, which indicated that shedding of CIP-resistant E. coli in cattle is positively correlated with a 
greater abundance of European starlings utilizing the associated production environments28.
In assessments of β-lactam resistance among the isolates collected in this study, the presence of blaAmpC-CIT was 
often found in conjunction with broad-spectrum resistance to β-lactams, including 3G-C antimicrobials such as 
CTX and CAZ, as well as monobactams represented by ATM. Resistance phenotypes involving reduced suscep-
tibility to 3G-C, and monobactams are commonly mediated by extended-spectrum and AmpC β-lactamases42,43. 
CMY-2 is considered to be the most common type of plasmid-mediated AmpC β-lactamase, frequently isolated 
from patients in hospitals, livestock, and ground meat44–46. It should be noted that the majority of isolates char-
acterized in our study, including those containing presumptive plasmid-mediated AmpCs, were determined to 
belong to the phylogenetic group B1. This phylogroup comprises primarily commensal bacteria7, which have 
been shown to resist stress and persist better in the environment47. Additionally, E. coli phylogenetic group B1 
was previously found in European starlings sampled in Ireland24, providing an indication of host preferences for 
Figure 3. In silico assessments of AMR genes found within 66 E. coli isolates collected from European starlings 
that were predicted to confer resistance to quinolones. CARD-RGI analyses of isolates identified 7 genes that 
putatively confer resistance to quinolones. An additional 12 genes putatively involved in efflux of both β-lactams 
and quinolones were identified (see Supplementary Table 3). The column labeled ‘AMR’ represents phenotypic 
resistance characterization, and it is matched by row to the genotypic data presented in the left side columns. 
Cells shaded in white indicate that the gene was not present or the isolate was susceptible to the particular drug.
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this phylogroup. PCR, which we utilized as a screening tool for select antimicrobial resistance genotypes, was gen-
erally in excellent agreement with outcomes of WGS characterization. When discrepancies occurred, these were 
primarily due to incomplete coverage of the primer sets utilized, or a limitation associated with short-read 
sequencing, which generally results in partial genomes.
A large percentage of the isolates in our study were resistant to TET and CAM. To date, TET resistance 
remains one of the most commonly encountered resistances in E. coli48. TET resistance has been associated 
with decreased susceptibility to SXT and AMP in E. coli from food animals in multiple European countries. The 
resistance genetic determinants to these antimicrobials are often found on the same mobile genetic elements, 
potentially reflecting the history of antimicrobial use in these countries49. The high percentages of resistance to 
CAM in our isolates were somewhat unusual. Only two of the isolates sequenced here encoded specific exporters 
recognized to confer resistance to phenicols (60 of the 66 isolates sequenced had clinical-resistance to CAM). 
However, several mechanisms are associated with CAM resistance in bacteria50, including target site mutations or 
modifications51, acetylation via acetyltransferases or chloramphenicol phosphotransferases52,53, efflux pumps54, 
and decreased outer membrane permeability55. Additionally, we note that CAM is banned for use in veterinary 
medicine (including food animals) in the United States due to issues related to its toxicity56,57. Nevertheless, flor-
fenicol (fluorinated synthetic analog of thiamphenicol, a CAM analog) is used to treat respiratory infections in 
cattle and resistance to this antibiotic is documented in livestock and may be co-selective58,59.
Here, we assessed the phenotypic and genetic diversity of AMR E. coli isolates collected from European star-
lings found on CAFOs in order to improve our understanding of the role of these birds in the transmission of 
AMR in livestock production systems. We utilized an array of methods, ranging from culture-based to molecular 
screening to select for priority phenotypes and genotypes for advanced molecular typing and characterization. 
We selected priority phenotypes and genotypes for downstream WGS analysis in order to facilitate phylogenetic 
and AMR determinant characterization; however, this approach would not be considered optimal should the 
goals of the study benefit from determination of genomic diversity in all isolates.
This study shows that E. coli isolated from these birds have important AMR phenotypes and genes, including 
those which confer resistance to fluoroquinolones and β-lactam antimicrobials, including 3G-C. Our study also 
identified phylogenetically conserved E. coli isolates in geographically separated European starlings, highlight-
ing a potential link between this invasive agricultural pest and interstate dissemination of AMR in food animal 
production.
Materials and Methods
Study sites, collection of avian fecal specimens, and culture-based isolation.  Feedlots with 
severe European starling problems (e.g., experiencing more than 10,000 European starlings per day) were pre-
viously identified using methodology established for identifying bird damage associated with dairies60. Samples 
from 31 feedlots in Colorado (n = 8 feedlots, 400 birds), Iowa (n = 5 feedlots, 150 birds), Kansas (n = 8 feedlots, 
443 birds), Missouri (n = 3 feedlots, 119 birds), and Texas (n = 7 feedlots, 365 birds) were collected between 
Figure 4. (a) Phylogenetic analysis of the core genomes of 66 E. coli isolates from European starlings. The color-
coded outer ring shows the U.S. state in which the individual isolates were collected. Isolates are labelled by their 
sample ID #, predicted serotype, and location (state and CAFO ID). Colored stars marked at adjacent branches 
indicate isolate groups showing high sequence and coding region similarity (see Supplementary Table 4). (b) 
Map displaying an approximate location of CAFOs, and the proportion of all 236 CTX-resistant (yellow) or 
CIP-resistant (blue) E. coli isolates collected from these sites, with circle size proportionate to the total number 
of isolates collected from these sites.
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December 4, 2012 and March 12, 2013. Up to 30 European starlings were collected at each livestock facility 
per day following methods approved by the United States Department of Agriculture (USDA) National Wildlife 
Research Center’s (NWRC) Animal Care and Use Committee. European starling collections were conducted 
using shotguns as set forth by agency policy in the USDA/Animal and Plant Health Inspection Service (APHIS)/
Wildlife Services (WS) Directive 2.505. Identifying information was recorded for each bird collected, including an 
assigned facility number, time and date of collection, and location of collection. Bird carcasses were individually 
bagged in sterile Whirl-Pak bags (Nasco, Fort Atkinson, WI) and shipped overnight at 4 °C to our laboratories 
for processing.
Culture-based isolation.  The gastrointestinal tract, from proventriculus to cloaca, was removed from each 
European starling, placed into a sterile Whirl-Pak bag (Nasco, Fort Atkinson, WI), and homogenized for 120 sec 
at 230 rpm using a Stomacher 400 Circulator (Seward, Islandia, NY). The resulting homogenate was inoculated 
using a sterile cotton tipped applicator onto MacConkey agar (Acumedia, Lansing, MI) (MAC) supplemented 
with 2 μg/mL CTX (Calbiochem, EMD Millipore, Billerica, MA) and onto MAC supplemented with 1 μg/mL 
CIP (Enzo Life Sciences, Farmingdale, NY) and incubated at 37 °C for 24 hr. From each media, 1–2 presumptive 
E. coli colonies (occasionally lactose negative isolates were also collected) were subcultured on either MAC-CTX 
or MAC-CIP to yield purified isolates. Purified isolates were propagated overnight in Brain Heart Infusion Broth 
(BD, Franklin Lakes, NJ) at 37 °C with shaking at 200 rpm, then mixed 1:1 in 40% glycerol, and stored at −80 °C 
until further use.
Isolate confirmation.  Species-level confirmation was performed on all bacterial isolates presumptively 
identified as E. coli via culture-based methods by MALDI biotyping using a formic acid-acetonitrile extraction 
procedure61. Briefly, one loopful (approximate volume of 1 μl) of bacteria was suspended in a 1:3 solution of 
HPLC grade water (Sigma-Aldrich, St. Louis, MO) and absolute ethanol (Sigma-Aldrich). According to the 
manufacturer’s protocol, bacteria were collected by centrifugation at 17,000 × g, pellets were allowed to air dry, 
and then suspended 1:1 in acetonitrile (Sigma-Aldrich, St. Louis, MO) and 70% formic acid (Sigma-Aldrich, 
St. Louis, MO). Insoluble material was pelleted by centrifugation as described above and 1 μl of the supernatant 
was applied to a polished steel target plate (Bruker, Billerica, MA). Samples were air-dried and overlaid with 1 μl 
of freshly prepared α-cyano-4-hydroxycinnamic acid (Bruker, Billerica, MA). MALDI biotyping for genus and 
species identification was accomplished using a Bruker Ultraflex II TOF/TOF or Bruker Microflex LRF (Billerica, 
MA) operating with Bruker Biotyper RTC software (Version 3.1) and pre-calibrated with Bruker Bacterial Test 
Standard. Species level identification of the isolates was accepted if a score of ≥1.7 was assigned by the MALDI 
Biotyper algorithm. While species-level identification is not secure with a score of ≤2.0, a lower score (≥1.7) was 
accepted when supported by culture-based identification.
Antimicrobial susceptibility testing.  Antimicrobial susceptibility testing of E. coli isolates was performed 
in accordance with Clinical and Laboratory Standards Institute’s (CLSI) M100-S24 protocols62. Sensi-Discs 
impregnated with the following antibiotics were used: gentamicin (GEN), tobramycin (TOB), AMC, IPM, CFZ, 
CTX, FOX, ceftazidime (CAZ), CIP, SXT, fosfomycin (FOF), ATM, nitrofurantoin (NIT), AMP, PIP, CAM, nali-
dixic acid (NAL), and TET. Antimicrobial susceptibilities were classified as sensitive, intermediate, or resistant 
based on the measured zones of inhibition and CSLI-established cutoffs62.
PCR-based phylotyping and detection of select AMR genes conferring β-lactam resist-
ance.  Phylotype grouping (Supplementary Table 6) was performed using a triplex PCR as previously 
described by Clermont et al.63. Briefly, all DNA was prepared via conventional boil-prep. The conventional PCR 
assay targeted chuA, yjaA and an anonymous DNA fragment (tspE.C2). An Applied Biosystems 2720 thermal 
cycler (Foster City, CA) was used for amplification. This procedure permitted classification of the isolates into 
phylogroups. The class A ß-lactamase genes blaCTX-M, blaSHV, blaTEM and CIT-type AmpCs were detected in a 
one-step multiplex PCR reaction as previously described by Roschanski et al. using a CFX96 Touch Real-Time 
PCR Detection System (Bio-Rad laboratories, Hercules, CA, USA) (Supplementary Table 6)46. All primers and 
probes were from Integrated DNA Technologies, Inc. (Coralville, IA).
Whole genome sequencing and analysis.  The epidemiological, phenotypic, and PCR data collected 
were used to prioritize a subset of isolates for genetic analyses by WGS. Priority was given to E. coli isolates with 
similar AMR phenotypes collected between multiple sampling locations and with clinically significant 3G-C 
resistance (n = 66).
DNA libraries were prepared using the Nextera XT chemistry with Nextera XT version 2 indexes (Illumina, 
San Diego, CA, USA). The DNA from each isolate was subject to bead-based size exclusion to optimize DNA frag-
ment size in accordance with standard procedures64. Using the Illumina NextSeq with 150 bp paired-end reads, 
5 ng of each sample were pooled and analyzed. The resultant reads were scanned for contamination with Kraken65, 
trimmed for quality using Trimmomatic (ILLUMINACLIP:BBmapAdapters.fasta:2:30:10 HEADCROP:10 
SLIDINGWINDOW:4:24 MINLEN:100)66, and assembled via SPAdes v3.13 (assemble only, kmer values 21, 33, 
55, 77)67. Structural and functional annotation of the resultant scaffolds was achieved with Prokka v1.13 (Genera: 
Escherichia)68. Unrooted core genome phylogeny comparisons were completed using Parsnp (with GenBank 
accession ASM584v2 as the reference genome) and visualized in FigTree v1.4.4 (http://tree.bio.ed.ac.uk/software/
figtree)69–72. For assembly metrics see Supplementary Table 773. Highly similar isolate groups were further inter-
rogated via Spine v0.3.1 (core assignment must occur in all genomes, minimum percent identity of alignments 
at the nucleotide level = 75, minimum core assignment size = 200 bp, maximum distance between core genome 
segments = 10 bp, see Supplementary Table 4)74–76. The Resistance Gene Identifier tool and Comprehensive 
Antibiotic Resistance Database (web version) run on the Prokka amino acid predications were used to identify 
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determinants putatively involved in antibiotic resistance77. Additional subtyping analyses for serotype predic-
tions, multilocus sequence typing, fimH type, fumC type, and plasmid identification were performed using tools 
available at the Center for Genomic Epidemiology (http://www.genomicepidemiology.org/)78–80. E. coli STs were 
further evaluated using the Enterobase database (https://enterobase.warwick.ac.uk/species/index/ecoli, accessed 
10/2/19).
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